Mon, Apr 24, 2023
Sun Pharma share price: These actions include retaining an independent Current Good Manufacturing Practice expert to conduct batch certifications of drugs manufactured at the Mohali facility.
More >
Mon, May 29, 2017
Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
